Steward Partners Investment Advisory’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Steward Partners Investment Advisory’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,030	Closed	-$66K	–	2822
2019 Q4	$66K	Buy	20,030 +4,000	+25%	+$12.7K	﹤0.01%	1288
2019 Q3	$48K	Sell	16,030 -625	-4%	-$1.76K	﹤0.01%	1375
2019 Q2	$39K	Sell	16,655 -500	-3%	-$1.49K	﹤0.01%	1434
2019 Q1	$64K	Buy	17,155 +3,900	+29%	+$14.6K	﹤0.01%	784
2018 Q4	$47K	Buy	13,255 +300	+2%	+$1.3K	﹤0.01%	762
2018 Q3	$74K	Buy	12,955 +2,650	+26%	+$15.2K	﹤0.01%	1036
2018 Q2	$52K	Buy	10,305 +3,625	+54%	+$18.7K	﹤0.01%	1093
2018 Q1	$34K	Buy	+6,680	New	+$40.2K	﹤0.01%	1139

Steward Partners Investment Advisory's FOMX Position: Q1 2020 in Review

Steward Partners Investment Advisory sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 20,030 shares — an estimated $66K sold.

Steward Partners Investment Advisory first reported a position in FOMX in Q1 2018 and held it in 8 quarters. The position peaked at $74K in Q3 2018. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Steward Partners Investment Advisory reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 20,030 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $66K.
Steward Partners Investment Advisory first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 8 quarters.
Steward Partners Investment Advisory's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $74K in Q3 2018.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2020, filed 29 Apr 2020.